Basedow disease
Kétli, K.; Kétli, K.
Orvosi Hetilap 140(40): 2239-2241
1999
ISSN/ISBN: 0030-6002 PMID: 10540900 Document Number: 504582
Document emailed within 1 workday
Related Documents
Goday-Arnó, A.; García Rico, A.; Martínez-Riquelme, A.; Cano-Pérez, J.F. 1996: Graves Basedow disease following treatment with magistral formulae for obesity. Jod-Basedow phenomenon? Revista Clinica Espanola 196(8): 536-538Pelizzo, M.R.; Toniato, A.; Girelli, M.E.; Grigoletto, R.; Bernante, P.; Pagetta, C.; Busnardo, B. 1996: Which thyroidectomy in Basedow disease? Minerva Chirurgica 51(12): 1071-1077
Wuttke, H. 1978: Pathogenesis of Basedow's disease Fortschritte der Medizin 96(46): 2325-2328
Lamberg, B.A. 1971: Problems in Basedow's disease Duodecim; Laaketieteellinen Aikakauskirja 87(12): 967-974
Rösler, H. 1976: Radioiodine treatment in Basedow's disease Schweizerische Medizinische Wochenschrift 106(36): 1215-1218
Ito, K. 1978: Basedow's disease--recent problems Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1200-1201
Hatotani, N. 1971: Psychotic symptoms in Basedow's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 29(5): 1324-1327
Bizzarro, A.; Fontana, A.; De Bellis, A.; Daponte, A.; Gentile, S.; Castello, G.; Iacono, G. 1987: TAC-positive lymphocytes in Basedow's disease Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 2(2): 118-124
Schifferdecker, E. 1990: The course of diffuse hyperthyroidism in Basedow disease Fortschritte der Medizin 108(1): 42-44
Lazzarin, M.; Segattini, L.; Benati, F. 1993: The pharmacological therapy of Basedow's disease Recenti Progressi in Medicina 84(10): 698-708
Hanzlik, J.; Mardarowicz, G. 1976: Graves-Basedow disease and pregnancy Polski Tygodnik Lekarski 31(52): 2239-2241
Hugon, S.; Pierrot, M.; Blaise, M.; Gabry, A.L.; Cupa, M. 1984: Anesthesia in surgery of Basedow's disease Cahiers d'Anesthesiologie 32(2): 107-111
Orgiazzi, J.; Guinet, P.; Rousset, H.; Pousset, G.; Tourniaire, J. 1971: Familial Basedow's disease (18 cases in 8 families) Lyon Medical 226(14): 155-161
Lungu, G.; Zosin, I.; Miloş, A.; Vlad, A.; Radu, M.; Popescu, D.; Toro, L.; Velea, P.; Opreanu, R.; Radu, H. 1988: Epidemiological aspects of Graves'-Basedow's disease Endocrinologie 26(2): 107-111
Manero Ruiz, F.J.; Playán Usón, J.; Acha Pérez, J.; Sanz París, A. 1998: Methimazole arthritis in Graves Basedow disease Anales de Medicina Interna 15(1): 47-48
Fazakas, S.; Kiss, B.; Erdei, I.; Petrányi, G. 1975: Hypothyreosis after I-131 therapy of Graves-Basedow disease Orvosi Hetilap 116(43): 2523-2526
Arteaga, E.; Campusano, C.; Michaud, P. 1993: Basedow-Graves disease development in 2 patients with primary hypothyroidism: exceptional development of the autoimmune thyroid disease Revista Medica de Chile 121(11): 1300-1304
Mouroux, D.; Martin Laval, A.; Bovero, G.; Nicolino, J. 1991: Neonatal hyperthyroidism secondary to Basedow's disease in the mother Presse Medicale 20(4): 167-170
Martí Cabané, J. 2003: Graves-Basedow disease, factors that influence in their relapse Anales de Medicina Interna 20(7): 388
Moser, E. 1997: Radioiodine therapy of Basedow's disease--is there a therapeutic standard? Zentralblatt für Chirurgie 122(4): 227-230